Annual Shareholders Equity
$387.88 M
+$87.46 M+29.11%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual stockholders equity is currently $387.88 million, with the most recent change of +$87.46 million (+29.11%) on 31 December 2023. During the last 3 years, it has risen by +$218.28 million (+128.71%). CPRX annual shareholders equity is now at all-time high.CPRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$660.94 M
+$52.29 M+8.59%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly stockholders equity is currently $660.94 million, with the most recent change of +$52.29 million (+8.59%) on 30 September 2024. Over the past year, it has increased by +$312.39 million (+89.63%). CPRX quarterly shareholders equity is now at all-time high.CPRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.1% | +89.6% |
| 3 y3 years | +128.7% | +232.7% |
| 5 y5 years | +663.8% | +747.5% |
CPRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +128.7% | at high | +232.7% |
| 5 y | 5 years | at high | +663.8% | at high | +747.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Catalyst Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $660.94 M(+8.6%) |
| June 2024 | - | $608.65 M(+8.4%) |
| Mar 2024 | - | $561.41 M(+44.7%) |
| Dec 2023 | $387.88 M(+29.1%) | $387.88 M(+11.3%) |
| Sept 2023 | - | $348.55 M(-7.1%) |
| June 2023 | - | $375.29 M(+12.5%) |
| Mar 2023 | - | $333.66 M(+11.1%) |
| Dec 2022 | $300.42 M(+45.2%) | $300.42 M(+11.3%) |
| Sept 2022 | - | $270.04 M(+12.0%) |
| June 2022 | - | $241.09 M(+9.5%) |
| Mar 2022 | - | $220.22 M(+6.5%) |
| Dec 2021 | $206.83 M(+22.0%) | $206.83 M(+4.1%) |
| Sept 2021 | - | $198.66 M(+5.1%) |
| June 2021 | - | $188.94 M(+5.8%) |
| Mar 2021 | - | $178.65 M(+5.3%) |
| Dec 2020 | $169.60 M(+93.5%) | $169.60 M(+8.3%) |
| Sept 2020 | - | $156.63 M(+40.9%) |
| June 2020 | - | $111.20 M(+11.6%) |
| Mar 2020 | - | $99.68 M(+13.7%) |
| Dec 2019 | $87.63 M(+72.6%) | $87.63 M(+12.4%) |
| Sept 2019 | - | $77.98 M(+23.2%) |
| June 2019 | - | $63.28 M(+23.7%) |
| Mar 2019 | - | $51.18 M(+0.8%) |
| Dec 2018 | $50.78 M(-37.3%) | $50.78 M(-20.7%) |
| Sept 2018 | - | $64.08 M(-9.8%) |
| June 2018 | - | $71.06 M(-6.8%) |
| Mar 2018 | - | $76.25 M(-5.8%) |
| Dec 2017 | $80.96 M(+106.0%) | $80.96 M(+155.2%) |
| Sept 2017 | - | $31.73 M(-6.6%) |
| June 2017 | - | $33.97 M(-3.2%) |
| Mar 2017 | - | $35.10 M(-10.7%) |
| Dec 2016 | $39.31 M(-29.1%) | $39.31 M(-8.4%) |
| Sept 2016 | - | $42.90 M(-7.4%) |
| June 2016 | - | $46.33 M(-8.3%) |
| Mar 2016 | - | $50.54 M(-8.9%) |
| Dec 2015 | $55.48 M | $55.48 M(-8.5%) |
| Sept 2015 | - | $60.65 M(-3.4%) |
| June 2015 | - | $62.79 M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $66.62 M(+89.0%) |
| Dec 2014 | $35.24 M(+64.8%) | $35.24 M(-3.8%) |
| Sept 2014 | - | $36.62 M(-11.1%) |
| June 2014 | - | $41.19 M(+133.5%) |
| Mar 2014 | - | $17.64 M(-17.5%) |
| Dec 2013 | $21.39 M(+46.3%) | $21.39 M(-3.3%) |
| Sept 2013 | - | $22.12 M(+124.7%) |
| June 2013 | - | $9.84 M(-23.8%) |
| Mar 2013 | - | $12.92 M(-11.6%) |
| Dec 2012 | $14.62 M(+288.8%) | $14.62 M(+55.6%) |
| Sept 2012 | - | $9.39 M(+46.5%) |
| June 2012 | - | $6.41 M(+136.0%) |
| Mar 2012 | - | $2.72 M(-27.8%) |
| Dec 2011 | $3.76 M(-31.8%) | $3.76 M(-3.0%) |
| Sept 2011 | - | $3.88 M(-21.8%) |
| June 2011 | - | $4.95 M(-21.2%) |
| Mar 2011 | - | $6.28 M(+13.9%) |
| Dec 2010 | $5.52 M(-27.6%) | $5.52 M(-8.0%) |
| Sept 2010 | - | $6.00 M(+10.9%) |
| June 2010 | - | $5.41 M(-18.7%) |
| Mar 2010 | - | $6.66 M(-12.6%) |
| Dec 2009 | $7.62 M(-27.9%) | $7.62 M(+60.0%) |
| Sept 2009 | - | $4.76 M(-20.3%) |
| June 2009 | - | $5.97 M(-22.1%) |
| Mar 2009 | - | $7.67 M(-27.4%) |
| Dec 2008 | $10.56 M(-35.3%) | $10.56 M(-25.0%) |
| Sept 2008 | - | $14.08 M(+10.5%) |
| June 2008 | - | $12.75 M(-15.0%) |
| Mar 2008 | - | $15.00 M(-8.1%) |
| Dec 2007 | $16.32 M(-17.8%) | $16.32 M(-5.0%) |
| Sept 2007 | - | $17.19 M(-3.6%) |
| June 2007 | - | $17.83 M(-5.4%) |
| Mar 2007 | - | $18.85 M(-5.0%) |
| Dec 2006 | $19.85 M(+4344.9%) | $19.85 M(+602.4%) |
| Sept 2006 | - | $2.83 M(-4183.1%) |
| June 2006 | - | -$69.20 K(-115.5%) |
| Dec 2005 | $446.50 K(+279.7%) | $446.50 K(+279.7%) |
| Dec 2004 | $117.60 K(+161.9%) | $117.60 K |
| Dec 2002 | $44.90 K | - |
FAQ
- What is Catalyst Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual shareholders equity year-on-year change?
- What is Catalyst Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Catalyst Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CPRX is $387.88 M
What is the all time high annual shareholders equity for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual stockholders equity is $387.88 M
What is Catalyst Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CPRX annual stockholders equity has changed by +$87.46 M (+29.11%)
What is Catalyst Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CPRX is $660.94 M
What is the all time high quarterly shareholders equity for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly stockholders equity is $660.94 M
What is Catalyst Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CPRX quarterly stockholders equity has changed by +$312.39 M (+89.63%)